Yunnan Hengchu Pharmaceutical Co., Ltd. is a holding subsidiary of Hunan Hengzhong Pharmaceutical Co., Ltd. Leveraging the parent company's industrial foundation and technical accumulation, it focuses on the R&D, production, and supply of active pharmaceutical ingredients (APIs) and intermediates. It is a modern pharmaceutical enterprise integrating research and development, production, and technological innovation. The company deeply cultivates the field of pharmaceutical raw materials, focusing on high-value-added chemical raw material production. With strong R&D capabilities, a standardized production system, and forward-looking industrial planning, it provides high-quality raw material solutions for the chemical and other related industries.
The company attaches great importance to technological R&D and talent development, establishing comprehensive professional laboratories in organic chemistry, materials chemistry, drug synthesis, pharmaceutical analysis, and material analysis to provide solid technical support for raw material R&D and quality testing. We have established deep cooperation with renowned domestic universities such as Central South University, China Pharmaceutical University, Nanjing University, and National University of Defense Technology, boasting 8 doctoral supervisor advisors and 12 professor partners. The R&D center is equipped with a high-end team including 10 PhDs, 11 Masters, and 25 undergraduates, forming a multi-level, professional R&D talent echelon to ensure product technological innovation and quality stability.
Aminocyclopropanecarboxylic Acid (Cosmetic Ingredient Name: Coagulacid) is one of the company's core production products in Phase I. As a classic whitening ingredient in the cross-border beauty industry, it has become a core choice for whitening and spot-fading skincare products thanks to its gentle and effective characteristics in fading spots and brightening skin.
Puerin is a high-end natural beauty ingredient prioritized by the company in Phase I. Extracted from the dried mature fruits of the legume plant *Puerin*, it is known as "Plant Retinol" and "Natural Retinol Alternative" due to its similar structure to retinol and lack of irritation. It is a star ingredient with multi-functional benefits including anti-aging, whitening, and anti-inflammatory properties, making it ideal for high-end skincare R&D.
Yunnan Hengchu Pharmaceutical Co., Ltd. is a holding subsidiary of Hunan Hengzhong Pharmaceutical Co., Ltd. Leveraging the parent company's industrial foundation and technical accumulation, the company focuses on the R&D, production, and supply of active pharmaceutical ingredients (APIs) and intermediates. It is a modern pharmaceutical enterprise integrating R&D, manufacturing, and technological innovation. The company specializes in the pharmaceutical raw material field, focusing on high-value-added specialty chemical raw materials. With strong R&D capabilities, standardized production systems, and forward-looking industrial planning, it provides high-quality raw material solutions for specialized industries.
In August 2020, the company reached an agreement with Chuxiong High-tech Zone for active pharmaceutical ingredients and intermediates projects. The project covers a total planned area of 248 acres with a total planned investment of 1 billion RMB, to be constructed in two phases. Once completed, it will become an intelligent manufacturing base for raw materials that combines large-scale production with advanced biosynthesis technology advantages. Phase I focuses on the production of core ingredients such as ammonium cyclohexane carboxylate and saikosaponin, construction began in September 2023. Infrastructure is currently complete, and workshop equipment has entered the installation and commissioning phase. Trial production is expected to begin in August 2026. Once fully operational, it can achieve an annual output value of 500 million RMB with a yearly profit tax of 100 million RMB, while providing 120 professional jobs. Phase II is scheduled to start in the second half of 2027 and go into production by the end of 2028, aiming to establish a world-leading biosynthesis intelligent manufacturing center and further enhance the industrial layout.
Yunding District, Cangling Industrial Park, Chuxiong High-Tech Zone, Yunnan Province
info@ynhcyy.com
+86 18173156789